Loading company…
Riskpilot
← Back to search
Sign in
Get full access
zenji labs IVS
IVS
Bankrupt
CVR 37222046
Gardes Alle 11, st.
Computerprogrammering · NACE 620100
Est. 2015
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2018
DKK 82K
-22% vs 2017
EBITDA margin
3.4%
-64% vs 2017
Equity ratio
22.2%
Financial strength
Net profit 2018
DKK 3K
-64% vs 2017
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
0%
2017
0M
0%
2018
Key figures
Annual report 2018
Revenue
DKK 82K
-22%
EBITDA
DKK 3K
-64%
Net profit
DKK 3K
-64%
Total assets
DKK 56K
+18%
Equity
DKK 12K
+29%
Employees
—
—
Company information
Legal name
zenji labs IVS
CVR number
37222046
Legal form
Iværksætterselskab
NACE code
620100 · Computerprogrammering
Founded
11. november 2015
Share capital
DKK 1
Employees
1
VAT registered
No
Audit selected
No
Last report
2018-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Gardes Alle 11, st.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computerprogrammering
Companies in Gentofte
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
Income statement
DKK thousands
Item
2016
2017
2018
Revenue
42
105
82
Staff expenses
-54
-0
-0
EBITDA
-12
8
3
Depreciation & amort.
-0
-0
-0
EBIT
-12
8
3
Net financials
0
0
0
Profit before tax
-12
8
3
Tax
-0
-0
-0
Net profit
-12
8
3
Balance sheet
DKK thousands
Item
2016
2017
2018
Total assets
25
47
56
Equity
-12
10
12
Long-term debt
0
0
0
Short-term debt
37
38
44
Total debt
37
38
44
Financial ratios
5-year trend
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
2016
2018
Equity ratio
22.2%
This company
38.2%
Market median
-42% vs market
2016
2018
Return on equity
22.4%
This company
18.4%
Market median
+22% vs market
2016
2018
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
2016
2018
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
2016
2018
Debt / equity
3.50×
This company
0.62×
Market median
-465% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2015-11-11 – 2016-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
SJ
Simon Jo Chizeck Andersen
Management
Management
2015
—
—
PB
Pernille Bigaard
Unofficial title
Unofficial title
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Risendo IVS
Company
100.0%
100.0%
2018
Nicolaj Sebastian Springer
Individual
50.0%
50.0%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of zenji labs IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Simon Jo Chizeck Andersen
Management
0 companies
Pernille Bigaard
Unofficial title
0 companies